home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Courses and Workshops  

Good Laboratory Practices (GLP) for Nonclinical Laboratory Studies

  January 24, 2018  
CfPIE - The Center for Professional Innovation & Education, Boston, MA USA
December 3 - 5, 2018

Course Description - Course runs 9:00 - 5:00 on Day 1 & Day 2 -- 9:00 - 3:00 on Day 3 (Breakfast & Lunch Included)

This course will provide participants with a comprehensive understanding of the terminology, regulations and mandated practices for GLP testing and compliance. Those attending will get a thorough briefing of the relevance of accurate documentation, calibration and maintenance of instruments and validation of relevant methodologies. 

The course also covers in detail issues involving the roles and responsibilities of the Study Director in planning, supervising and managing pre-clinical studies. Also, the analysis and reporting of study results will be discussed. Also included is a discussion of functions related to quality assurance unit responsibilities and the need to effectively audit laboratory activities and data for regulatory compliance. Successful audits are often a result of good planning and interaction between QA staff and management. This course will cover a range of audit activities (internal and external) including responsibilities and requirements for compliance including those required at collaborator sites, records management, GLP special requirements, archiving of data and inspections.

The roles and responsibilities of Quality Assurance in the control of daily activities, data collection, analysis and archiving of study information will be discussed. The roles of the Study Director and QA in regulatory and client inspections will also be presented.

The course also discusses how to manage regulatory inspections, and how to respond to regulatory findings and audits. Inspection results for sponsoring companies and CROs are included in these discussions.

 PLEASE NOTE: Proposed changes to the GLP Regulations were published by the FDA on August 25, 2016 and will be discussed.  The FDA will be accepting comments to the proposed changes for 120 days and will eventually publish all questions/comments with responses at some future date.

Major changes between the current regulations and the proposed revisions include significantly greater involvement of management in the quality system, the requirement to have a risk management program, control of electronic information and control of subcontracted services.

Who Should Attend

Good Laboratory Practices (GLP) generally refers to a quality system of management controls for laboratories and research organizations that regulates how non-clinical safety studies are planned, performed, monitored, recorded, reported and archived. Many Bioanalytical laboratories have also chosen to follow GLP as the quality system for the control of testing for pharmacokinetic and other clinical studies. This ensures the consistency and reliability of results for submissions to the USFDA, USEPA, the OECD and other national organizations.

This three-day GLP training course is designed for all Scientists (managerial and laboratory), Regulatory Affairs and Compliance personnel who are active in regulated laboratory studies. It will be of most benefit to professionals whose job function necessitates the generation, evaluation, assurance and submission of laboratory data to regulatory agencies. Principal Investigators, Study Directors, Study Monitors and professionals aspiring to these positions will derive benefit from this course.

This course is also useful for quality assurance and quality control managers, coordinators of multi-site projects, regulatory affairs professionals, auditors, and senior management interested in effective QA techniques. New and experienced staff from the food, pharmaceutical, medical device, nutraceutical, agrochemical and cosmetics industries will learn the fundamental principles and applications of GLP, particularly in the complex multi-site environments of today’s industry. The course will also benefit professionals from CROs that operate under the GLPs.

Organized by: Center for Professional Innovation & Education
Invited Speakers:

Kenneth Cleaver, Ph.D.

Specialties: Product Development, Regulatory

Dr. Kenneth Cleaver is a highly regarded GLP consultant with over 20 years of industry experience. Since 2001, Dr. Cleaver has taught GLP courses and consulted for a variety of organizations. These include Medtronic, M.D. Anderson Cancer Institute, Exxon-Mobil, Hewlett-Packard, Vertex Pharmaceuticals, and Phillips Oral Care. His experience covers such disciplines as basic research, drug re-formulation, medical device development, contract laboratory testing and environmental studies.

In addition to his role as a CfPIE Course Instructor, Dr. Cleaver is the Director of CfPIE’s GLP Facility Certification Program, which provides clients with the documentation they need in order to prove to the world that their facilities and quality systems are fully GLP compliant.

Prior to 2001, Dr. Cleaver served as Vice President of Product Development for Novadel (formerly Flemington Pharmaceutical). Before this, he was a consultant with Medical Development Quality Associates and directed the Quality Assurance Unit at Oread Laboratories – a CRO specialized in distribution, metabolism and excretion of drug substances in various animal species. He has also overseen toxicology studies in mice, rats, guinea pigs and dogs for such clients as Upjohn Laboratories, Marion Laboratories, Bristol-Myers Squibb and Burroughs-Wellcome.

Dr. Cleaver received his Ph.D. in Pharmaceutics and M.A. in Organic Chemistry from Temple University. He received his B.S. in Chemistry from Albright College.

Other Courses:

Deadline for Abstracts: N/A
Registration: https://www.cfpie.com/ProductDetails.aspx?ProductID=207
E-mail: info@cfpie.com
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.